Ambrosia Biosciences is a privately held drug discovery company developing orally delivered, small molecule-based therapies for obesity and other metabolic disorders.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
08/20/24	$16,000,000	Series A	Boulder Ventures BVF Partners	undisclosed
04/06/26	$100,000,000	Series B	Blue Owl Deep Track Capital Redmile Group	undisclosed